NCT05679310View on ClinicalTrials.gov

Innovative Biotechnological Production of Antioxidant Products

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

July 6, 2022

Study Completion Date

September 30, 2022

Conditions
Oxidative StressInflammationBody WeightHomocystine; Metabolic Disorder
Interventions
DIETARY_SUPPLEMENT

Hydroxytyrosol/Essential oils

A dietary supplement containing 10 mg of hydroxytyrosol, synthesised using genetically modified Escherichia coli strains and equal amounts (8.33 μL) of essential oils from oregano vulgaris, sage officinalis and crithmum maritimum.

Trial Locations (1)

45110

University of Ioannina, Ioannina

All Listed Sponsors
lead

University of Ioannina

OTHER